Department of Pediatrics, Washington University in St Louis, St Louis Children's Hospital.
Department of Biostatistics, Washington University in St Louis.
J Pediatr Gastroenterol Nutr. 2022 Jun 1;74(6):750-756. doi: 10.1097/MPG.0000000000003448. Epub 2022 Apr 19.
We characterized recent outcomes in US pediatric acute liver failure (PALF) subjects listed for liver transplantation (LT) using the Scientific Registry of Transplant Recipients (SRTR) database.
Pediatric subjects listed for LT from 2002 to 2015 were assigned to the "PALF" group based on status 1/1A listing, INR >2, no hepatic artery thrombosis, and no primary graft nonfunction (N = 397). Subjects were assigned to the "non-PALF" group if listed with any status other than 1/1A (N = 4509).
The PALF group had more infants <3 months of age and males at listing for LT compared to the non-PALF group. Two-thirds of PALF subjects had an indeterminate etiology. LT waitlist survival was significantly worse in the PALF group compared to the non-PALF group. Likelihood of removal from the LT waitlist for being "too sick" was higher, while that of removal for "spontaneous recovery" was lower in PALF subjects. Post-LT short-term (30 days) and long-term (60 months) outcomes were also significantly worse in PALF versus non-PALF subjects. PALF subjects who underwent living-donor-liver-transplant (LDLT) had similar LT waitlist times and post-LT survival compared to those undergoing deceased-donor-liver-transplant (DDLT). Over the study period, we observed a decreased number of liver transplants, and increase in LT waitlist- and short-term post-LT-survival in PALF subjects.
LT waitlist and post-LT outcomes are worse in PALF subjects compared to non-PALF subjects. PALF subjects who undergo LDLT have similar waitlist times and post-LT outcomes compared to those undergoing DDLT.
我们利用美国移植受者科学注册处(SRTR)数据库对接受肝移植(LT)的美国儿科急性肝衰竭(PALF)患者的近期结局进行了特征描述。
2002 年至 2015 年,根据状态 1/1A 列表、INR>2、无肝动脉血栓形成和无原发性移植物功能障碍,将 LT 名单上的儿科患者分为“PALF”组(N=397)。如果名单上的状态不是 1/1A,则将患者分配到“非 PALF”组(N=4509)。
与非 PALF 组相比,LT 名单上的 PALF 组有更多的<3 个月大的婴儿和男性。PALF 患者中有三分之二的病因不明。与非 PALF 组相比,PALF 组 LT 候补名单的存活率明显较差。因“病情太重”而从 LT 候补名单中删除的可能性较高,而因“自发恢复”而删除的可能性较低。PALF 患者 LT 后短期(30 天)和长期(60 个月)结局也明显较差。与接受尸体供肝移植(DDLT)的患者相比,接受活体供肝移植(LDLT)的 PALF 患者的 LT 候补名单时间和 LT 后生存率相似。在研究期间,我们观察到肝移植数量减少,以及 PALF 患者 LT 候补名单和 LT 后短期生存率增加。
与非 PALF 患者相比,LT 候补名单和 LT 后结局较差。与接受 DDLT 的患者相比,接受 LDLT 的 PALF 患者的候补名单时间和 LT 后结局相似。